Gene ID 81793
Formulation 50 µg (0.5 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA and 0.02% thimerosal.
Antibody Target TLR10
Shipping gel pack
Concentration 0.5 mg/ml
Storage Temp. -20 °C
Appearance Colorless liquid
Research Use For Rersearch Use Only! Not to be used in humans.
Shelf Life 1 year
Handling The peptide solution should be gently mixed before use.
Test You can block the antibody by the specific target amino acid sequence of peptide.
Properties blocking peptide
Description Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
Short name TLR10 Blocking Peptide
Technique blocking peptide, Blocking, peptide
Alternative name toll-like receptor 10 inhibiting short protein sequence
Alternative technique control
Alternative to gene target toll-like receptor 10, TLR10 and IDBG-13548 and ENSG00000174123 and 81793, protein binding, Plasma membranes, TLR10 and IDBG-641604 and ENSBTAG00000014042 and 539791